The leader of a pioneering biotech company in the siRNA space weighs his options for scaling production capacity in advance of an anticipated commercial launch. Operational complexity and relative merits of in-house manufacturing versus a contractor model are discussed.

【書誌情報】

ページ数：13ページ

サイズ：A4

商品番号：HBSP-617022

発行日：2016/11/14

登録日：2017/2/21